A carregar...

Assessing monoclonal antibody product quality attribute criticality through clinical studies

Recombinant therapeutic proteins, including antibodies, contain a variety of chemical and physical modifications. Great effort is expended during process and formulation development in controlling and minimizing this heterogeneity, which may not affect safety or efficacy and, therefore, may not need...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Goetze, Andrew M, Schenauer, Matthew R, Flynn, Gregory C
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2958571/
https://ncbi.nlm.nih.gov/pubmed/20671426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.2.5.12897
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!